Qun‐Ying Lei

36.6k total citations · 6 hit papers
108 papers, 11.7k citations indexed

About

Qun‐Ying Lei is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Qun‐Ying Lei has authored 108 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 41 papers in Cancer Research and 24 papers in Cell Biology. Recurrent topics in Qun‐Ying Lei's work include Cancer, Hypoxia, and Metabolism (36 papers), Epigenetics and DNA Methylation (22 papers) and Hippo pathway signaling and YAP/TAZ (20 papers). Qun‐Ying Lei is often cited by papers focused on Cancer, Hypoxia, and Metabolism (36 papers), Epigenetics and DNA Methylation (22 papers) and Hippo pathway signaling and YAP/TAZ (20 papers). Qun‐Ying Lei collaborates with scholars based in China, United States and India. Qun‐Ying Lei's co-authors include Kun‐Liang Guan, Bin Zhao, Yue Xiong, Shimin Zhao, Li Li, Zhengyu Zha, Yiping Wang, Chen‐Ying Liu, Xin Zhou and Di Zhao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Qun‐Ying Lei

106 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version

2010 935 citations Qun‐Ying Lei, Kun‐Liang Guan et al. profile →
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

2009 896 citations Shimin Zhao, Yan Lin et al. Science profile →
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

2003 835 citations Qun‐Ying Lei et al. profile →
TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway

2008 785 citations Qun‐Ying Lei, Zhengyu Zha et al. profile →
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

2011 543 citations Chen‐Ying Liu, Qun‐Ying Lei et al. profile →
D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

2022 160 citations Ruonan Zhang, Yajing Yang et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Qun‐Ying Lei

Since Specialization

Citations

This map shows the geographic impact of Qun‐Ying Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qun‐Ying Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qun‐Ying Lei more than expected).

Fields of papers citing papers by Qun‐Ying Lei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qun‐Ying Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qun‐Ying Lei. The network helps show where Qun‐Ying Lei may publish in the future.

Co-authorship network of co-authors of Qun‐Ying Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Qun‐Ying Lei. A scholar is included among the top collaborators of Qun‐Ying Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qun‐Ying Lei. Qun‐Ying Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Excessive STAU1 condensate drives mTOR translation and autophagy dysfunction in neurodegeneration 2024 ·The Journal of Cell Biology ·(unknown), (unknown), (unknown), (unknown), Minjie Fu, Wei Hua, Ying Mao, Qun‐Ying Lei, Boxun Lu, Wenyu Wen	4
2	ER-associated degradation ligase HRD1 links ER stress to DNA damage repair by modulating the activity of DNA-PKcs 2024 ·Proceedings of the National Academy of Sciences ·(unknown), Guixue Hou, Shanliang Zheng, (unknown), (unknown), Qingyu Lin, Hao Liu, Xingwen Wang, (unknown), Yuhan Wei, (unknown), Yi Zhang, Chaoran Liu, (unknown), Qun‐Ying Lei, Ying Hu	4
3	Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression 2023 ·Nature Metabolism ·(unknown), Na Li, Xiaochen Lu, Midie Xu, Ying Liu, (unknown), Yi Zhang, Kewen Hu, Yuting Qi, Jun Yao, Yingli Wu, Wenyu Wen, Shenglin Huang, Zhengjun Chen, Miao Yin, Qun‐Ying Lei	50
4	TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential 2023 ·Cell Discovery ·Jing He, Mingen Lin, Xinchao Zhang, Ruonan Zhang, Tongguan Tian, (unknown), (unknown), Yajing Yang, (unknown), Yue Dai, Yue Xu, (unknown), Ming Xu, Qun‐Ying Lei, Yanping Xu, Lei Lv	9
5	Aldolase A Accelerates Cancer Progression by Modulating mRNA Translation and Protein Biosynthesis via Noncanonical Mechanisms 2023 ·Advanced Science ·(unknown), Hongquan Li, Yanfang Liu, Xinrong Li, Qili Shi, Qun‐Ying Lei, Weiguo Hu, Shenglin Huang, Zhiao Chen, Xianghuo He	21
6	CRISPR/Cas9 Screens Reveal that Hexokinase 2 Enhances Cancer Stemness and Tumorigenicity by Activating the ACSL4‐Fatty Acid β‐Oxidation Pathway 2022 ·Advanced Science ·Hongquan Li, (unknown), Yifei He, Yizhe Liu, Zhen Liu, Weili Sun, Weiguo Hu, Qun‐Ying Lei, Xin Hu, Zhiao Chen, Xianghuo He	52
7	D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1 breakdown → 2022 ·Proceedings of the National Academy of Sciences ·Ruonan Zhang, Yajing Yang, Wenjing Dong, Mingen Lin, Jing He, Xinchao Zhang, Tongguan Tian, Yunlong Yang, Kun Chen, Qun‐Ying Lei, Song Zhang, Yanping Xu, Lei Lv	160
8	A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinoma 2022 ·Computers in Biology and Medicine ·Qili Shi, Yizhe Liu, (unknown), Qun‐Ying Lei, Zhiao Chen, Lu Wang, Xianghuo He	10
9	TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling 2022 ·Cancer Research ·(unknown), Shuyan Li, Jing He, (unknown), Ruonan Zhang, Wenjing Dong, Mingen Lin, Yajing Yang, Tongguan Tian, (unknown), Yixin Xu, Qun‐Ying Lei, Jing Zhang, Qing Zhang, Yanping Xu, Lei Lv	34
10	AHCYL1 senses SAH to inhibit autophagy through interaction with PIK3C3 in an MTORC1-independent manner 2021 ·Autophagy ·Wei Huang, Na Li, Yi Zhang, Xu Wang, Miao Yin, Qun‐Ying Lei	22
11	TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer 2021 ·Nature Communications ·Jiahui Xu, Xiaoli Yang, Qiaodan Deng, Yang Cong, Dong Wang, (unknown), Xiaohong Yao, (unknown), (unknown), (unknown), Juchuanli Tu, Rui Zhang, Qun‐Ying Lei, Zhimin Shao, Xiu‐Wu Bian, Ronggui Hu, Lixing Zhang, Suling Liu	50
12	BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma 2020 ·Nature Cell Biology ·Jintao Li, Miao Yin, Di Wang, Jian Wang, Mingzhu Lei, Ye Zhang, Ying Liu, Lei Zhang, Shaowu Zou, Li-Peng Hu, Zhigang Zhang, Yiping Wang, Wenyu Wen, Haojie Lu, Zhengjun Chen, Dan Su, Qun‐Ying Lei	174
13	FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis 2020 ·Molecular Oncology ·Wei Zhang, Xin Zhang, Sheng Huang, Jianfeng Chen, Peipei Ding, Qi Wang, Luying Li, Xinyue Lv, Ling Li, Pingzhao Zhang, (unknown), Wenyu Wen, Yiping Wang, Qun‐Ying Lei, Jiong Wu, Weiguo Hu	45
14	NOTCH1 Signaling Regulates Self-Renewal and Platinum Chemoresistance of Cancer Stem–like Cells in Human Non–Small Cell Lung Cancer 2017 ·Cancer Research ·Yun Zhang, Wei Xu, Huiqin Guo, Yanmei Zhang, (unknown), Sau Har Lee, Xin Song, Xiaoyan Li, Yongqing Guo, Yunlong Zhao, Cheng Ding, (unknown), Yuanyuan Ma, Qun‐Ying Lei, Xiaoyu Hu, Shengnan Li, Wei Guo	75
15	Oxidative Stress Activates SIRT2 to Deacetylate and Stimulate Phosphoglycerate Mutase 2014 ·Cancer Research ·Yanping Xu, Fulong Li, Lei Lv, Tingting Li, Xin Zhou, Chu‐Xia Deng, Kun‐Liang Guan, Qun‐Ying Lei, Yue Xiong	128
16	NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells 2014 ·Journal of Clinical Investigation ·Di Zhao, Yan Mo, (unknown), (unknown), (unknown), (unknown), Yue Xiong, Kun‐Liang Guan, Qun‐Ying Lei	133
17	Glyceraldehyde-3-phosphate Dehydrogenase Is Activated by Lysine 254 Acetylation in Response to Glucose Signal 2013 ·Journal of Biological Chemistry ·Tingting Li, Mengxi Liu, Xu Feng, Zhen Wang, (unknown), Yanping Xu, Xin Zhou, Yiping Sun, Kun‐Liang Guan, Yue Xiong, Qun‐Ying Lei	77
18	The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase 2010 ·Journal of Biological Chemistry ·Chen‐Ying Liu, Zhengyu Zha, Xin Zhou, Heng Zhang, Wei Huang, Di Zhao, Tingting Li, Siew Wee Chan, Chun Jye Lim, Wanjin Hong, Shimin Zhao, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan	435
19	PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ 2010 ·Journal of Biological Chemistry ·Chen‐Ying Liu, (unknown), Tingting Li, Yanping Xu, Xin Zhou, Shimin Zhao, Yue Xiong, Qun‐Ying Lei, Kun‐Liang Guan	111
20	Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α breakdown → 2009 ·Science ·Shimin Zhao, Yan Lin, Wei Xu, Wenqing Jiang, Zhengyu Zha, Pu Wang, Wei Yu, Zhiqiang Li, Ling-Ling Gong, Yingjie Peng, Jianping Ding, Qun‐Ying Lei, Kun‐Liang Guan, Yue Xiong	896

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact